Skip to main content

Table 3 Mean hours spent in each pain severity state over 48-h period

From: Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial

 

Mean (SD) hours in pain state

 

Complete case analysis

MNAR imputation analysis

Pain states

Zav (n = 327)

PBO (n = 303)

Mean difference

Cohen’s D

P-value

Zav (n = 623)

PBO (n = 646)

Mean difference

Cohen’s D

P-value

None

35.9 (13.7)

33.1 (15.0)

 + 2.8

0.195

0.016

26.9 (17.8)

23.2 (18.0)

 + 3.7

0.207

 < 0.001

Mild

7.8 (9.6)

9.5 (10.2)

 − 1.7

−0.172

0.033

9.9 (9.1)

10.8 (9.6)

 − 0.9

−0.096

0.070

Moderate

3.3 (6.4)

4.4 (7.7)

 − 1.1

−0.155

0.050

8.7 (10.8)

11.1 (12.3)

 − 2.4

−0.207

 < 0.001

Severe

1.0 (3.7)

1.0 (3.1)

0

0.000

0.842

2.5 (4.8)

2.9 (5.0)

 − 0.4

−0.082

0.188

  1. Abbreviations: MNAR missing not at random, PBO placebo, SD standard deviation, zav zavegepant